Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1)

Journal of Biological Chemistry

Volumn 288, Issue 29, 2013, Pages 20927-20941

  Li, Yongkui ^a,b   Xie, Jiajia ^a   Xu, Xiupeng ^a   Liu, Li ^a   Wan, Yushun ^a   Liu, Yingle ^a   Zhu, Chengliang ^a   Zhu, Ying ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITIES; ANTIVIRAL RESPONSE; IMMUNE RESPONSE; REGULATORY ELEMENTS; SELECTIVE STIMULATIONS; VIRAL INFECTIONS;

BIOCHEMISTRY; BIOLOGY;

VIRUSES;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 29; INTERLEUKIN 32; MICRORNA 29B;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPORATION; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDRODYNAMICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VIRUS REPLICATION;

CYTOKINES/INTERFERON; GENE REGULATION; HOST-PATHOGEN INTERACTIONS; INFECTIOUS DISEASES; INTERLEUKIN; VIRAL IMMUNOLOGY;

ANIMALS; ANTIVIRAL AGENTS; BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; HYDRODYNAMICS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NF-KAPPA B; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84880565969     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.440115     Document Type: Article

References (49)

1. Joosten, L. A., Netea, M. G., Kim, S. H., Yoon, D. Y., Oppers-Walgreen, B., Radstake, T. R., Barrera, P., van de Loo, F. A., Dinarello, C. A., and van den Berg, W. B. (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 103, 3298-3303
2. Andoh, A. (2008) Mucosal cytokine network in inflammatory bowel disease. World J. Gastroenterol. 14, 5154-5161
3. Netea, M. G., Azam, T., Lewis, E. C., Joosten, L. A., Wang, M., Langenberg, D., Meng, X., Chan, E. D., Yoon, D.-Y., Ottenhoff, T., Kim, S.-H., and Dinarello, C. A. (2006) Mycobacterium tuberculosis induces interleu-kin-32 production through a caspase-1/IL-18/interferon-7-dependent mechanism. PLoS Med. 3, e277
4. Nold, M. F., Nold-Petry, C.A., Pott, G. B., Zepp, J.A., Saavedra, M. T., Kim, S. H., and Dinarello, C. A. (2008) Endogenous IL-32 controls cytokine and HIV-1 production. J. Immunol. 181, 557-565
5. Netea, M. G. (2005) IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1 and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 102, 16309-16314
6. Kim, S. H., Han, S. Y., Azam, T., Yoon, D. Y., and Dinarello, C. A. (2005) Interleukin-32: a cytokine and inducer of TNFa. Immunity 22,131-142
7. Li, W., Sun, W., Liu, L., Yang, F., Li, Y., Chen, Y., Fang, J., Zhang, W., Wu, J., and Zhu, Y. (2010) IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J. Immunol. 185, 5056 -5065
8. Rasool, S. T., Tang, H., Wu, J., Li, W., Mukhtar, M. M., Zhang, J., Mu, Y., Xing, H. X., Wu, J., and Zhu, Y. (2008) Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol. Lett. 117,161-167
9. Moschen, A. R., Fritz, T., Clouston, A. D., Rebhan, I., Bauhofer, O., Barrie, H. D., Powell, E. E., Kim, S. H., Dinarello, C. A., Bartenschlager, R., Jonsson, J. R., and Tilg, H. (2011) Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Hepa-tology 53,1819-1829
10. Zepp, J. A., Nold-Petry, C. A., Dinarello, C. A., and Nold, M. F. (2011) Protection from RNA and DNA viruses by IL-32. J. Immunol. 186, 4110-4118
11. Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., Raveche, E., and Kotenko, S. V. (2006) Characterization of the mouse IFN-A ligand-receptor system: IFN-As exhibit antitumor activity against B16 melanoma. Cancer Res. 66, 4468-4477
12. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., and Donnelly, R. P. (2003) IFN-As mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77
13. Maher, S. G., Sheikh, F., Scarzello, A. J., Romero-Weaver, A. L., Baker, D. P., Donnelly, R. P., and Gamero, A. M. (2008) IFNa and IFNA differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol. Ther. 7, 1109-1115
14. Robertsen, B. (2006) The interferon system of teleost fish. Fish Shellfish Immunol. 20, 172-191
15. Bandi, P., Pagliaccetti, N. E., and Robek, M. D. (2010) Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. J. Interferon Cytokine Res. 30, 123-134
16. Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., Os-trander, C., Dong, D., Shin, J., Presnell, S., Fox, B., Haldeman, B., Cooper, E., Taft, D., Gilbert, T., Grant, F. J., Tackett, M., Krivan, W., McKnight, G., Clegg, C., Foster, D., and Klucher, K. M. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63- 68
17. Almeida, G. M., de Oliveira, D. B., Magalhaes, C. L., Bonjardim, C. A., Ferreira, P. C., and Kroon, E. G. (2008) Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus. Antiviral Res. 80, 302-308
18. Robek, M. D., Boyd, B. S., and Chisari, F. V. (2005) A interferon inhibits hepatitis B and C virus replication. J. Virol. 79, 3851-3854
19. Hong, S. H., Cho, O., Kim, K., Shin, H. J., Kotenko, S. V., and Park, S. (2007) Effect of interferon-A on replication of hepatitis B virus in human hepa-toma cells. Virus Res. 126, 245-249
20. Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J. M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., Goke, B., and Dambacher, J. (2005) IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G960-G968
21. Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., and Palu-dan, S. R. (2006) A interferon (IFN-A), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80, 4501-4509
22. Marukian, S., Andrus, L., Sheahan, T. P., Jones, C. T., Charles, E. D., Ploss, A., Rice, C. M., and Dustin, L. B. (2011) Hepatitis C virus induces interfer-on-A and interferon-stimulated genes in primary liver cultures. Hepatol-ogy 54,1913-1923
23. Choi, H. J., Dinarello, C. A., and Shapiro, L. (2001) Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J. Infect. Dis. 184, 560-568
24. Kim, K.-H., Shim, J.-H., Seo, E.-H., Cho, M.-C., Kang, J.-W., Kim, S.-H., Yu, D.-Y., Song, E.-Y., Lee, H.-G., Sohn, J.-H., Kim, J., Dinarello, C. A., and Yoon, D.-Y. (2008) Interleukin-32 monoclonal antibodies for Immunohis-tochemistry, Western blotting, and ELISA. J. Immunol. Methods 333, 38 -50
25. Lee, S., Kim, S., Bae, S., Choi, J., Hong, J., Ryoo, S., Jhun, H., Hong, K., Kim, E., Jo, S., and Her, E. (2010) Interleukin-327 specific monoclonal antibody and developing IL-32 specific ELISA. Hybridoma 29, 501-509
26. Li, W., Liu, Y., Mukhtar, M. M., Gong, R., Pan, Y., Rasool, S. T., Gao, Y., Kang, L., Hao, Q., Peng, G., Chen, Y., Chen, X., Wu, J., and Zhu, Y. (2008) Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 3, e1985
27. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak, K. J., and Guegler, K. J. (2005) Real-time quantification of microR-NAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179
28. Yan, X., Hao, Q., Mu, Y., Timani, K. A., Ye, L., Zhu, Y., and Wu, J. (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxy-genase-2 by binding directly to regulatory elements for nuclear factor-αB and CCAAT/enhancer binding protein. Int. J. Biochem. Cell Biol. 38, 1417-1428
29. McMahon, B. J. (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49, S45-55
30. Keller, S. A., Schattner, E. J., and Cesarman, E. (2000) Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96, 2537-2542
31. Sells, M. A., Chen, M. L., and Acs, G. (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 84, 1005-1009
32. Pan, Y., Wei, W., Kang, L., Wang, Z., Fang, J., Zhu, Y., and Wu, J. (2007) NS5A protein of HCV enhances HBV replication and resistance to interferon response. Biochem. Biophys. Res. Commun. 359, 70-75
33. Stoll-Becker, S., Repp, R., Glebe, D., Schaefer, S., Kreuder, J., Kann, M., Lampert, F., and Gerlich, W. H. (1997) Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J. Virol. 71, 5399-5407
34. Wu, K., Mu, Y., Hu, J., Lu, L., Zhang, X., Yang, Y., Li, Y., Liu, F., Song, D., Zhu, Y., and Wu, J. (2007) Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. Antiviral Res. 74, 142-149
35. Gottwein, J.M., Scheel, T. K., Hoegh, A.M., Lademann, J. B., Eugen-Olsen, J., Lisby, G., and Bukh, J. (2007) Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133,1614-1626
36. Yang, P. L., Althage, A., Chung, J., and Chisari, F. V. (2002) Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. U.S.A. 99, 13825-13830
37. Wu, C., Deng, W., Deng, L., Cao, L., Qin, B., Li, S., Wang, Y., Pei, R., Yang, D., Lu, M., and Chen, X. (2012) Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J. Virol. 86, 4658-4669
38. Pasquinelli, C., Laure, F., Chatenoud, L., Beaurin, G., Gazengel, C., Bismuth, H., Degos, F., Tiollais, P., Bach, J. F., and Brechot, C. (1986) Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J. Hepatol. 3, 95-103
39. Lobbiani, A., Lalatta, F., Lugo, F., and Colucci, G. (1990) Hepatitis B virus transcripts and surface antigen in human peripheral blood lymphocytes. J.Med. Virol. 31,190-194
40. Jung, M. C., Stemler, M., Weimer, T., Spengler, U., Dohrmann, J., Hoffmann, R., Eichenlaub, D., Eisenburg, J., Paumgartner, G., and Riethmuller, G. (1991) Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus. Hepatology 13, 637- 643
41. Hutvagner, G., and Zamore, P. D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056-2060
42. Doench, J. G. (2004) Specificity of microRNA target selection in transla-tional repression. Genes Dev. 18, 504-511
43. Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K., and Kaneko, S. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49,1098-1112
44. Thomson, S. J., Goh, F. G., Banks, H., Krausgruber, T., Kotenko, S. V., Foxwell, B. M., and Udalova, I. A. (2009) The role oftransposable elements in the regulation of IFN-A1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 106,11564-11569
45. Benn, J., Su, F., Doria, M., and Schneider, R.J. (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J.Virol. 70, 4978-4985
46. Benn, J., and Schneider, R. J. (1995) Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. U.S.A. 92, 11215-11219
47. Su, F., and Schneider, R. J. (1996) Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J. Virol. 70, 4558-4566
48. Matikainen, S., Siren, J., Tissari, J., Veckman, V., Pirhonen, J., Severa, M., Sun, Q., Lin, R., Meri, S., Uze, G., Hiscott, J., and Julkunen, I. (2006) Tumor necrosis factor a enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80,3515-3522
49. Thanos, D., and Maniatis, T. (1995) Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100